Journals / Turkish Journal of Internal Medicine / 2026 / Volume: 3 Issue: Supplement 1 Special Issue

Polycystic Renal Disease Presented by Anuria and Nephrolithiasis Associated Progressive Kidney Damage: A Case Report

Müge Karacakayalılar(BURSA MUSTAFAKEMALPAŞA DEVLET HASTANESİ)0000-0002-6545-8640
Selman Candan(BURSA ULUDAĞ ÜNİVERSİTESİ, TIP FAKÜLTESİ, DAHİLİ TIP BİLİMLERİ BÖLÜMÜ, RADYOLOJİ ANABİLİM DALI)0000-0002-4742-296X
Mehmet Çiçek(BURSA ULUDAĞ ÜNİVERSİTESİ, TIP FAKÜLTESİ, CERRAHİ TIP BİLİMLERİ BÖLÜMÜ, ÜROLOJİ ANABİLİM DALI)0000-0002-0471-5404
Abdülmecit Yıldız(BURSA ULUDAĞ ÜNİVERSİTESİ, TIP FAKÜLTESİ, DAHİLİ TIP BİLİMLERİ BÖLÜMÜ, İÇ HASTALIKLARI ANABİLİM DALI, NEFROLOJİ BİLİM DALI)0000-0001-5941-9103
Münevver İrem Kök(TOKAT ZİLE DEVLET HASTANESİ)0000-0001-5687-3642
Pages
—
Publication Date
2021-03-07
🏛️Bibliographic metadata and full text access for this article are provided via DergiPark.
DergiPark Record ↗
✨

AI Summary & Key Takeaways

AI Insight
⚡ TL;DR(Too Long; Didn't Read)

Here, we present a case with ADPKD whose renal functions rapidly deteriorated while under chronic follow-up and renal function markers returned to the basal levels with the treatment of the underlying cause.

📌 3 Key Takeaways

🎯
Objective & Hypothesis:Autosomal Dominant Polycystic Kidney Disease (ADPKD) is the most common inherited kidney disease.
📊
Key Findings & Data:Kidney stones develop in 20-30% of patients with ADPKD.Hydronephrosis, which is the most valuable radiological finding in the diagnosis of stone-related postrenal insufficiency, may be difficult to differentiate from common cysts in ADPKD patients.
💡
Conclusion & Impact:Here, we present a case with ADPKD whose renal functions rapidly deteriorated while under chronic follow-up and renal function markers returned to the basal levels with the treatment of the underlying cause.
🔬Design:Short Report
📍Scope:Comprehensive Sample
⚙️Variables:Anuria · Nephrolithiasis · Polycystic renal disease

Abstract

Autosomal Dominant Polycystic Kidney Disease (ADPKD) is the most common inherited kidney disease. Kidney stones develop in 20-30% of patients with ADPKD.Hydronephrosis, which is the most valuable radiological finding in the diagnosis of stone-related postrenal insufficiency, may be difficult to differentiate from common cysts in ADPKD patients. When kidney dysfunction develops in ADPKD patients, Glomerular Filtration Rate (GFR) loss reaches an average of 4.4 to 5.9 mL / min per year. Faster deterioration in these patients requires investigation for prerenal factors such as dehydration that triggers acute kidney damage or stone-related postrenal factors. In ADPKD, stone-related postrenal obstruction should be considered in rapid GFR losses despite negative ultrasound report for hydronephrosis as there is frequent occurrence of kidney stones and the difficulty in detecting hydronephrosis with ultrasonography (US) in these patients. Here, we present a case with ADPKD whose renal functions rapidly deteriorated while under chronic follow-up and renal function markers returned to the basal levels with the treatment of the underlying cause.

🔖

Cite This Article

Karacakayalılar, M., Candan, S., Çiçek, M., Yıldız, A., Kök, M. İ. (2021). Polycystic Renal Disease Presented by Anuria and Nephrolithiasis Associated Progressive Kidney Damage: A Case Report. Turkish Journal of Internal Medicine, Volume: 3 Issue: Supplement 1 Special Issue. https://doi.org/10.46310/tjim.866999

📄 Full Text PDF Viewer

📄

PDF görüntüleyici hazırlanıyor...

References (10)

  1. Torres VE, Harris PC, Pirson Y. Autosomal dominant polycystic kidney disease. Lancet. 2007 Apr 14;369(9569):1287-1301. doi: 10.1016/S0140-6736(07)60601-1.
  2. Kalatharan V, Grewal G, Nash DM, Welk B, Sarma S, Pei Y, Garg AX. Stone prevalence in autosomal dominant polycystic kidney disease: A systematic review and meta-analysis. Can J Kidney Health Dis. 2020 Jul 4;7:1-19. doi: 10.1177/2054358120934628.
  3. Gaur P, Gedroyc W, Hill P. ADPKD-what the radiologist should know. Br J Radiol. 2019 Jun;92(1098):20190078. doi: 10.1259/bjr.20190078.
  4. Veser J, Özsoy M, Seitz C. Congenital and acquired diseases related to stone formation. Curr Opin Urol. 2018 Sep;28(5):414-9. doi: 10.1097/MOU.0000000000000522.
  5. Mallett A, Patel M, Tunnicliffe DJ, Rangan GK. KHA-CARI autosomal dominant polycystic kidney disease guideline: Management of renal stone disease. Semin Nephrol. 2015 Nov;35(6):603-6.e3. doi: 10.1016/j.semnephrol.2015.10.012.
  6. Ghata J, Cowley BD Jr. Polycystic kidney disease. Compr Physiol. 2017 Jun 18;7(3):945-75. doi: 10.1002/cphy.c160018.
  7. Mufti UB, Nalagatla SK. Nephrolithiasis in autosomal dominant polycystic kidney disease. J Endourol. 2010 Oct;24(10):1557-61. doi: 10.1089/end.2010.0093.
  8. Chapman AB, Devuyst O, Eckardt KU, Gansevoort RT, Harris T, Horie S, Kasiske BL, Odland D, Pei Y, Perrone RD, Pirson Y, Schrier RW, Torra R, Torres VE, Watnick T, Wheeler DC; Conference Participants. Autosomal-dominant polycystic kidney disease (ADPKD): executive summary from a Kidney Disease: Improving Global Outcomes (KDIGO) Controversies Conference. Kidney Int. 2015 Jul;88(1):17-27. doi: 10.1038/ki.2015.59.
  9. Grantham JJ. Clinical practice. Autosomal dominant polycystic kidney disease. N Engl J Med. 2008 Oct 2;359(14):1477-85. doi: 10.1056/NEJMcp0804458.
  10. Skolarikos A, Alivizatos G, de la Rosette J. Extracorporeal shock wave lithotripsy 25 years later: complications and their prevention. Eur Urol. 2006 Nov;50(5):981-90; discussion 990. doi: 10.1016/j.eururo.2006.01.045.